Cantor Fitzgerald downgrades Affimed Therapeutics (AFMD) to NeutralCantor Fitzgerald analyst Li Watsek downgraded Affimed Therapeutics (NASDAQ: AFMD) from Overweight to Neutral.
Cantor Fitzgerald downgrades Affimed Therapeutics (AFMD) to NeutralCantor Fitzgerald analyst Li Watsek downgraded Affimed Therapeutics (NASDAQ: AFMD) from Overweight to Neutral.
trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of -2.74% per trade.
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of -19.08% per trade.
Copying Yale Jen's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -9.10% per trade.
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -29.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AFMDQ Analyst Recommendation Trends
Rating
Sep 24
Nov 24
Dec 24
Jan 25
May 25
Strong Buy
6
5
9
9
7
Buy
9
9
5
2
1
Hold
3
10
16
18
15
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
24
30
29
23
In the current month, AFMDQ has received 8Buy Ratings, 15Hold Ratings, and 0Sell Ratings. AFMDQ average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
AFMDQ Stock Forecast FAQ
What is AFMDQ’s average 12-month price target, according to analysts?
Currently, no data Available
What is AFMDQ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AFMDQ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AFMDQ a Buy, Sell or Hold?
Currently, no data Available
What is Affimed’s price target?
Currently, no data Available
What do analysts say about Affimed?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of AFMDQ?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.